Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (12 ops.)
Latest filing published 07 Sept 2026 for Genscript Biotech Corporation, €6,836.
Filing timeline
BuySaleZhu Li
Insider track record
Disclosed buys
6
Disclosed sells
12
Signal history
Closed purchases
Market purchases
6
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- +197.9%Entry HK$11.64 · Close at T+90 HK$34.68
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Zhu Li: trading record in brief
Zhu Li discloses dealings in 2 companies, chiefly Genscript Biotech Corporation and First Service Holding Ltd. In total, 21 filings cover trades dated from 8 December 2020 to 2 September 2026.
Market trades split into 6 purchases (€10k) and 12 sales (€1.7M). No amount is published for 4 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 1 purchase and 5 sales on the market.
The median purchase comes to €2,147.
On 7 September 2026 came the latest disclosure, an open-market sale for €6,836 in Genscript Biotech Corporation. The last purchase on record was published on 9 June 2026, which is 137 days ago. The median gap between a trade and its publication by HKEX is 4 days. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to Zhu Li
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
1,737 shares@ HK$35.74480.0001% mcap1.3% of flowShareXHKGHKEX:DA20260904E00486
32,883 shares@ HK$35.93330.0012% mcap23.8% of flowShareXHKGHKEX:DA20260904E00485
34,000 shares@ HK$33.180.0011% mcap22.6% of flowShareXHKGHKEX:DA20260821E00331
98,085 shares@ HK$26.07980.0026% mcap51.6% of flowShareXHKGHKEX:DA20260821E00330
113,041 sharesShareXHKGHKEX:DA20260609E00347
Canonical exit: 2 Sept 2026 (T+90)
3,029 shares@ HK$12.12060.0001% mcap0.7% of flowShareXHKGHKEX:DA20260609E00348
100,000 sharesShareXHKGHKEX:DA20220916E00372
14,037 shares@ HK$31.9801ShareXHKGHKEX:DA20220104E00442
33,000 shares@ HK$40.8848ShareXHKGHKEX:DA20211213E00642
33,000 shares@ HK$8.33ShareXHKGHKEX:DA20211213E00640
33,000 shares@ HK$40.6045ShareXHKGHKEX:DA20211213E00641
33,000 shares@ HK$8.33ShareXHKGHKEX:DA20211213E00639
42,000 shares@ HK$39.10ShareXHKGHKEX:DA20211129E00176
57,514 shares@ HK$37.3286ShareXHKGHKEX:DA20211129E00175
12,500 shares@ HK$0.87ShareXHKGHKEX:DA20210830E00183
Canonical exit: 23 Nov 2021 (T+90)
100,000 sharesShareXHKGHKEX:DA20210603E00517
Canonical exit: 29 Aug 2021 (T+90)
20,000 shares@ HK$1.02ShareXHKGHKEX:DA20210106E00006
Canonical exit: 30 Mar 2021 (T+90)
200,000 sharesShareXHKGHKEX:DA20201231E00404
Canonical exit: 28 Mar 2021 (T+90)
67,500 shares@ HK$0.9978ShareXHKGHKEX:DA20201221E00156
Canonical exit: 16 Mar 2021 (T+90)
271,840 shares@ HK$12.551ShareXHKGHKEX:DA20201210E00243
518,320 shares@ HK$0.597ShareXHKGHKEX:DA20201210E00242
21 of 21 declarations
